2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST‐Elevation Myocardial Infarction (Updating the 2007 Guideline): Highlights for the Clinician

Clinical Cardiology - Tập 35 Số 1 - Trang 3-8 - 2012
Nanette K. Wenger1
1Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia

Tóm tắt

AbstractThe 2011 Update to the Unstable Angina/Non–ST‐Elevation Myocardial Infarction (UA/NSTEMI) Guideline is based in evolving data or expert opinion and incorporates information from late‐breaking clinical trials presented at the 2008–2009 Scientific Sessions of the American College of Cardiology, the American Heart Association, and the European Society of Cardiology, among others, as well as selected data through April 2010.The 5 key issues highlighted in this summary are: (1) the timing of acute interventional therapy in non–ST‐elevation myocardial infarction; (2) emphasis on the timing, duration, and application of dual and triple antiplatelet therapy; (3) specific recommendations for patients with diabetes mellitus; (4) the role and potential benefit of invasive therapy in patients with advanced renal dysfunction; and (5) issues of quality improvement for acute coronary syndromes. © 2011 Wiley Periodicals, Inc.Dr. Wenger is a consultant at Emory Heart and Vascular Center, Atlanta, Georgia. The author has no other funding, financial relationships, or conflicts of interest to disclose.

Từ khóa


Tài liệu tham khảo

10.1016/j.jacc.2011.02.009

10.1001/jama.290.12.1593

10.1056/NEJMoa0807986

10.1001/jama.2009.1267

10.1056/NEJMoa0706482

10.1016/S0140-6736(10)61088-4

10.1056/NEJMoa0909475

10.1056/NEJMoa0904327

American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents, American Heart Association, Society of Cardiovascular Angiography and Interventions, 2010, ACCF/AHA clopidogrel clinical alert: approaches to the FDA “boxed warning” : a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association, J Am Coll Cardiol., 56, 321, 10.1016/j.jacc.2010.05.013

10.1161/CIRCULATIONAHA.109.851949

10.1093/eurheartj/ehp157

10.1056/NEJMoa1007964

10.1016/j.jacc.2010.09.010

10.1056/NEJMoa0901316

10.1001/jama.297.6.591

10.2337/dc09-9029

10.1016/j.jacc.2009.10.015

10.1056/NEJMoa0810625

10.1001/jama.2009.496

10.1161/01.CIR.99.20.2626

10.1056/NEJMoa052521

10.1016/S0002-9149(02)02844-8

10.7326/0003-4819-137-7-200210010-00007

10.2215/CJN.05551008

10.1161/CIRCULATIONAHA.109.865352

10.1093/ndt/14.5.1064

10.1056/NEJM199411243312104

10.1016/S0002-9149(02)02771-6

10.1016/j.jacc.2007.03.058

10.1161/CIRCULATIONAHA.108.838169

10.1161/CIRCULATIONAHA.108.191099

American Heart Association. Get With the Guidelines.http://www.americanheart.org/presenter.jhtml?identifier=1165. Accessed June 10 2009.

National Cardiovascular Data Registry. Action RegistryGWTG.http://www.ncdr.com/webncdr/ACTION/Default.aspx. Accessed June 10 2009.

QualityNet.com. Measure Comparison (Inpatient Hospital Quality Measures).http://www.qualitynet.org/dcs/ContentServer?c=Page&pagename=QnetPublic%2FPage%2FQnetTier3&cid=1138900298473. Accessed June 10 2009.

The Joint Commission. Acute Myocardial Infarction Core Measure Set.http://wwwjointcommission.org/PerformanceMeasurement/Acute+Myocardial+Infarction+Core+Measure_Set.htm. Accessed June 10 2009.

10.1001/jama.2010.1320

Brilinta (ticagrelor) [package insert].Wilmington DE: AstraZeneca.http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022433s000lbl.pdf.

10.1056/NEJMoa0905561

Thông tin
Thông tin xuất bản

Clinical Cardiology

Tập 35 Số 1

3-8

Thông tin tác giả